Agata Kosmaczewska at Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences - Research Interests, Publications & Academic Profile

Agata Kosmaczewska

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences

Poland

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Chinese students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

80%

Virology

30%

Inflammatory Biology

40%

T Cell Biology

30%

Immune Response

20%

Covid-19

20%

Multiple Myeloma

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles9

Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors

Article Link

Year:

2023

BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production

Article Link

Year:

2021

Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients

Article Link

Year:

2021

Cytokines as predictors of COVID-19 severity: evidence from a meta-analysis. Authors' reply.

Article Link

Year:

2021

Imbalance in PB IL-17-Secreting and Regulatory Cells in Pars Planitis Is Associated with Dysregulation of IFN-γ-Secreting Cells, Especially in Patients with Clinical Complications

Article Link

Year:

2020

Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients

Article Link

Year:

2020

CD4+CD28null T cells are expanded in moderately active systemic lupus erythematosus and secrete pro-inflammatory interferon gamma, depending on the Disease Activity Index

Article Link

Year:

2020

Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes. Authors' reply.

Article Link

Year:

2020

Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019.

Article Link

Year:

2020

Collaborators8

Agnieszka Bojarska-Junak

Associate Professor/Ph.D, Hab.

Medical University of Lublin

POLAND

Anna Tomkiewicz

Ludwik Hirszfeld Institute of Immunology and Experimental Therapy

POLAND

Edyta Pawlak

Head of Laboratory / Associate Professor

Ludwik Hirszfeld Institute of Immunology and Experimental Therapy

POLAND

Dariusz Wołowiec

Medical University of Silesia

POLAND

Jacek Rolinski

Prof

Medical University of Lublin

POLAND

Anna Andrzejczak

Ludwik Hirszfeld Institute of Immunology and Experimental Therapy

POLAND

Lidia Ciszak

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences

POLAND

Lidia Usnarska-Zubkiewicz

Wroclaw Medical University

POLAND

How do Chinese students reach out?

Meet Kite AI